Temasek stated last week that income from assets in the United States and India were assisting it in reversing the effects of China’s performance decline. In light of the current industry conflicts, Temasek added that it is examining China cautiously.
For the first time in a decade, Temasek’s investments are concentrated in the United States, with 19 % concentrated in China, and its global footprint surpasses China in the most recent fiscal year.
Temasek invested US$ 3 billion in India during the fiscal year that ended on March 31; this is its largest annual investment thus much.
Bhandari added that as Temasek’s investment expands, it will look into hiring more investment professionals from the latest 20. He also declined to provide specifics.
Temasek’s present India coverage includes investments in HDFC Bank, IPO-bound e-scooter manufacturer Ola Electric and Manipal Clinics.
In the biggest hospital sector deal ever to be signed in India, Temasek spent US$ 2 billion to increase its stake in Manipal from 18 % to 59 %. It eventually sold a majority stake to Novo Nordisk’s family Novo Holdings and Abu Dhabi’s royal investment Mubadala.
As Indian hospitals and healthcare organizations expand into smaller places where private healthcare is increasingly needed because public hospitals are still overburdened, overseas investors are showing more and more interest in these industries.
Temasek will continue to look for additional investment opportunities in the medical industry because it thinks the industry is an “multi-decade” development story in India, according to Bhandari.